Vicapsys Life Sciences (VICP) Financial Statements
Vicapsys Life Sciences Financial Overview
Vicapsys Life Sciences's market cap is currently $14.57M. The company's EPS TTM is $-0.00; its P/E ratio is -23.08; Vicapsys Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ -31.29K | $ -31.33K |
| Operating Income | $ -651.80K | $ -813.84K | $ -1.05M | $ -984.79K | $ -336.87K |
| EBITDA | $ -651.80K | $ -900.14K | $ -1.02M | $ -613.27K | $ -305.54K |
| Net Income | $ -689.89K | $ -989.80K | $ -1.18M | $ -984.79K | $ -236.87K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.64K | $ 11.60K | $ 9.42K | $ 14.10K | $ 217.29K |
| Total Assets | $ 2.64K | $ 11.60K | $ 39.66K | $ 72.02K | $ 594.31K |
| Total Debt | $ 624.35K | $ 578.95K | $ 353.87K | $ 0.00 | $ 0.00 |
| Net Debt | $ 621.71K | $ 567.35K | $ 344.45K | $ -14.10K | $ -217.29K |
| Total Liabilities | $ 3.58M | $ 2.89M | $ 1.97M | $ 1.02M | $ 715.96K |
| Stockholders' Equity | $ -3.58M | $ -2.88M | $ -1.93M | $ -950.79K | $ -121.65K |
| Cash Flow | |||||
| Free Cash Flow | $ -21.46K | $ -121.66K | $ -417.52K | $ -238.20K | $ -443.97K |
| Operating Cash Flow | $ -21.46K | $ -121.66K | $ -417.52K | $ -238.20K | $ -443.97K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 100.00K |
| Financing Cash Flow | $ 12.50K | $ 123.83K | $ 412.85K | $ 35.00K | $ 560.00K |
Currency in USD